Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01304108 · ClinicalTrials.gov registry record · Phase 4
Improving Venous Thromboembolism Prophylaxis
A Phase 4 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 3,000
- Enrollment target
NCT01304108: Completed Phase 4 study, sponsored by Mayo Clinic.
NCT01304108 is a Phase 4 study that has completed, run by Mayo Clinic. The registered enrollment target is 3,000 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (479% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01304108, a Phase 4 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 3,000 participants
- Enrollment target
Study Summary
Preventing the formation of blood clots in the veins so they do not injure leg veins or travel to the lungs, also called venous thromboembolism prophylaxis (VTE-P) is an essential component of safe in-patient care, yet it is deployed sub-optimally in many hospitals, including The investigators own. Two prior VTE-P improvement projects were completed at Mayo Clinic hospitals, one in the Department of Medicine, and the other in selected divisions of the Department of Surgery. Both projects resulted in marked improvement in the percentage of patients receiving appropriate VTE-P. This project seeks to utilize the lessons learned from these two pilots along with known best practices for \"spreading\" to deploy methods that enhance VTE-P to the entire hospitalized population. The investigators seek appropriate VTE-P rates exceeding 95%.
Primary Outcome
The investigators will measure the number of patients in a statistically valid random sample of hospitalized patients who have a VTE-prophylaxis plan consistent with current recommendations.
Interventions
- OTHER Usual Care
- OTHER VTE-P Tollgate
- OTHER BLAZE Pop up
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2009-01 |
| Est. Completion | 2010-05 |
| Phase | Phase 4 |
What the finished NCT01304108 record still lists
NCT01304108 is an interventional study that assigns participants to a tested intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (479% higher).
The record links to 0 conditions, and to 3 interventions - of which Usual Care is the first listed.
NCT01304108 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01304108 about?
NCT01304108 is a clinical study titled "Improving Venous Thromboembolism Prophylaxis". Preventing the formation of blood clots in the veins so they do not injure leg veins or travel to the lungs, also called venous thromboembolism prophylaxis (VTE-P) is an essential component of safe in-patient care, yet it is deployed sub-optimally in many hospitals, including The investigators own. ...
What is the current status of trial NCT01304108?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 3,000 participants. The study started on 2009-01. Estimated completion is 2010-05.
What interventions are being tested in trial NCT01304108?
The interventions under investigation include: Usual Care (OTHER), VTE-P Tollgate (OTHER), BLAZE Pop up (OTHER).
Who is sponsoring clinical trial NCT01304108?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01304108's enrollment target sits among peer trials
3,000 25th of 2000 higher than 1,976 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia